Abstract:In the recent era, scientific interest has been piqued by Helicobacter pylori , a bacterium that resides in the human stomach and has been linked to a range of gastrointestinal disorders including gastritis, peptic ulcers, and an increased risk of gastric cancer. In this study, we conducted synthesis, characterization, DFT-based investigations, and in silico biological assessments of three novel dipeptide-sulphonamide derivatives to evaluate their potential as drug candidates targeting H. pylori receptors. The results of the vibrational energy distribution study were compared to the experimental vibrational frequencies, and they were found to be in good agreement. Investigation of intramolecular charge transfer interactions and stabilization energies was conducted through natural bond orbital (NBO) analysis. The analysis revealed a range of stabilization energies, with compound C exhibiting the highest energy of 657.15 kcal/mol, followed by compound A at 448.97 kcal/mol, and compound B at 418.97 kcal/mol. This order of stability correlates with their reactivity, as evidenced by energy values of 7.6693 eV for compound C, 8.4154 eV for compound A, and 8.9295 eV for compound B. These findings suggest that compound C is the most reactive among the studied species. The molecular docking results revealed that the ligands; N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(4-methylphenylsulphonamido) pentanamide (A ), N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(phenylsulphonamido) pentanamide (B), and N- (2(Isobutylamino)2-oxoethyl)3-methyl-2(4-nitrophenylsulphonamido) pentanamide (C) exhibited excellent selectivity and reactivity with the protein 2QV3 compared to the standard lansoprazole. The findings clearly show that these novel dipeptide-sulphonamides could represent a new class of potential anti-ulcer agents and, with further research, could be used as new anti-ulcer medications.

Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells.

Metronidazole–Deoxybenzoin Derivatives As Anti‐Helicobacter Pylori Agents with Potent Inhibitory Activity Against HPE‐Induced Interleukin‐8

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

6-gingerol and its derivatives inhibit Helicobacter pylori-induced gastric mucosal inflammation and improve gastrin and somatostatin secretion

Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.

The synthesis, structure and activity evaluation of secnidazole derivatives as helicobacter pylori urease inhibitors

Effects of Oiliness Extracts from Rose Family Plant Fruit Core Against Helicobacter Pylori in Vitro and in Vivo

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Indole-3-Lactic Acid Derived from Lacticaseibacillus paracasei Inhibits Helicobacter pylori Infection via Destruction of Bacteria Cells, Protection of Gastric Mucosa Epithelial Cells, and Alleviation of Inflammation

Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.

Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.

Synthesis, characterization, DFT studies, and in silico biological evaluation of novel dipeptide-sulphonamide derivatives against Helicobacter pylori receptors

Discovery of Cinnamic Acid Derivatives as Potent Anti-H. pylori Agents

Ethyl acetate extract of Kaempferia parviflora inhibits Helicobacter pylori-associated mammalian cell inflammation by regulating proinflammatory cytokine expression and leukocyte chemotaxis

Arylamino Containing Hydroxamic Acids As Potent Urease Inhibitors for the Treatment of Helicobacter Pylori Infection.

Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.

Anti- Helicobacter pylori substances from endophytic fungal cultures

Four novel anti-adhesive activity peptides against Helicobacter pylori derived from rice bran protein: release, identification and anti-adhesive mechanisms elucidation

Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo

Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral Helicobacter pylori relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression